COMP <GO>
FERG vs CUVL // PIOTROSKI F-SCORE QUALITY
Ferguson Enterprises Inc. (NYSE) VS. Clinuvel Pharmaceuticals Limited (NASDAQ) • 15-METRIC TALLY: FERG 4
— CUVL 7
▲ PIOTROSKI F-SCORE QUALITY LEADER: FERG
LAST: $240.45 (+4.21%) • MKT CAP: $46.52B
piotroski-score
7/9
LAST: $5.15 (+1.58%) • MKT CAP: $257.8M
piotroski-score
6/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FERG VS. CUVL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FERG | CUVL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 30.70% | 81.20% | -50.50 | CUVL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 22.20% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.2x | 9.7x | +3.50 | CUVL | /valuation <GO> |
| Free Cash Flow Yield | 1.13% | 10.51% | -9.38 | CUVL | /fcf-yield <GO> |
| Operating Margin | 8.50% | 43.40% | -34.90 | CUVL | /operating-margins <GO> |
| Net Profit Margin | 6.00% | 37.80% | -31.80 | CUVL | /net-margins <GO> |
| Revenue Growth (YoY) | 3.80% | 5.50% | -1.70 | CUVL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.05% | 0.66% | +0.39 | FERG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.66 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 7/9 | 6/9 | +1.00 | FERG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 68.4 | 41.2 | +27.20 | FERG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.00 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.3x | 10.3x | +13.00 | CUVL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $46.52B | $257.8M | $46.26B | FERG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FERG REV | CUVL REV | FERG GROSS % | CUVL GROSS % | FERG FCF | CUVL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $30.76B | $61.1M | 30.7% | 81.2% | $523.7M | $27.1M |
| FY 2024 | $29.64B | $57.9M | 30.5% | 81.5% | $539.4M | $20.1M |
| FY 2023 | $29.73B | — | — | — | $1.38B | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FERG // BETA 1.00
CUVL // BETA —